Completed PHASE2 INTERVENTIONAL 5-arm NCT01053962

SP-304 Dose Ranging Study in Patients With Chronic Idiopathic Constipation (CIC)

A Phase 2 Randomized, Double-Blind, Placebo-Controlled, 14-Day Repeat, Oral, Dose Ranging Study to Assess the Safety, Pharmacokinetic and Pharmacodynamic Effects of SP-304 in Patients With Chronic Idiopathic Constipation

Sponsor: Bausch Health Americas, Inc.

Conditions Chronic Idiopathic Constipation

Interventions Placebo SP-304 0.3 mg SP-304 1.0 mg SP-304 3.0 mg SP-304 9.0 mg

Updated 8 times since 2017 Last updated: Dec 16, 2019 Started: Mar 31, 2010 Primary completion: Aug 31, 2010 Completion: Aug 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01053962, this PHASE2 trial focuses on Chronic Idiopathic Constipation and remains completed. Sponsored by Bausch Health Americas, Inc., it has been updated 8 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Dec 2021 — Jul 2024 [monthly]

Completed PHASE2
Jan 2021 — Dec 2021 [monthly]

Completed PHASE2
Feb 2020 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 3 earlier versions

Jun 2018 — Feb 2020 [monthly]

Completed PHASE2
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Mar 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bausch Health Americas, Inc.

Data source: Bausch Health Americas, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Anaheim, United States , Chapel Hill, United States , Chesterfield, United States , Germantown, United States , Hialeah, United States , Longview, United States , Mesa, United States , Miami, United States , Nashville, United States , Orange, United States and 4 more locations